Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DT30ZG
|
|||
| Drug Name |
OP0201
|
|||
| Indication | Acute otitis media [ICD-11: AB00] | Phase 2 | [1] | |
| Company |
Novus Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03818815) A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.